ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET)
Publication
, Journal Article
Gururangan, S; Grant, GA; Driscoll, T; Archer, G; Sayour, EJ; Herndon, JE; Friedman, HS; Kurtzberg, J; Bigner, DD; Sampson, JH; Mitchell, DA
Published in: PEDIATRIC BLOOD & CANCER
September 1, 2013
Duke Scholars
Published In
PEDIATRIC BLOOD & CANCER
EISSN
1545-5017
ISSN
1545-5009
Publication Date
September 1, 2013
Volume
60
Start / End Page
13 / 13
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gururangan, S., Grant, G. A., Driscoll, T., Archer, G., Sayour, E. J., Herndon, J. E., … Mitchell, D. A. (2013). ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET). PEDIATRIC BLOOD & CANCER, 60, 13–13.
Gururangan, S., G. A. Grant, T. Driscoll, G. Archer, E. J. Sayour, J. E. Herndon, H. S. Friedman, et al. “ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET).” PEDIATRIC BLOOD & CANCER 60 (September 1, 2013): 13–13.
Gururangan S, Grant GA, Driscoll T, Archer G, Sayour EJ, Herndon JE, et al. ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET). PEDIATRIC BLOOD & CANCER. 2013 Sep 1;60:13–13.
Gururangan, S., et al. “ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET).” PEDIATRIC BLOOD & CANCER, vol. 60, WILEY-BLACKWELL, Sept. 2013, pp. 13–13.
Gururangan S, Grant GA, Driscoll T, Archer G, Sayour EJ, Herndon JE, Friedman HS, Kurtzberg J, Bigner DD, Sampson JH, Mitchell DA. ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET). PEDIATRIC BLOOD & CANCER. WILEY-BLACKWELL; 2013 Sep 1;60:13–13.
Published In
PEDIATRIC BLOOD & CANCER
EISSN
1545-5017
ISSN
1545-5009
Publication Date
September 1, 2013
Volume
60
Start / End Page
13 / 13
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences